NCT05790785Recruiting
Vascular Complications in Children From T1D Diagnosis
Understanding Vascular Complications in Children From Type 1 Diabetes Diagnosis
Source: ClinicalTrials.gov · Last updated 2 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Cardiovascular disease is a complication of type 1 diabetes (T1D), a life-long disease, usually diagnosed in childhood. The goal of this project is to determine the timing and factors leading to vascular damage in children from T1D diagnosis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 4 Aug 2022
- Start date
- Mar 2024
- Primary completion date
- Sept 2027
- Lead sponsor
- University of British Columbia
- Diseases
- Type 1 diabetes
- NCT number
- NCT05790785
What you commit to
- Study type: Observational
- Planned participants: 150
- From Mar 2024 to the primary completion date, Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Transgender children taking hormone blockers or exogenous sex steroids
- Currently treated with medications known to affect metabolism (e.g. glucocorticoids, antipsychotics).
Other illness
- Other cardiometabolic or endocrine diseases diagnosis (type 2 diabetes; familial disorders of cholesterol metabolism; lupus)
- Other genetic syndromes (Down Syndrome; Prader-Willi)
- Eating disorder diagnosis
Other
- Children will be ineligible to participate in the study if they meet any of the following:
Who the study is looking for
- Between the ages of 8-18 years
- Within 14 weeks of type 1 diabetes diagnosis
- Ability and willingness to undergo non-invasive arterial stiffness assessment for 1hr and willingness to wear the 24-h automated blood pressure monitoring (ABPM) device.
Age in the registry: 8 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Endocrine and Diabetes Unit, BC Children's Hospital Coordinator of this site? Confirm its status | Vancouver | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.